EuBiologics Co., Ltd. (KOSDAQ:A206650) announced a private placement of first unguaranteed non-detachable private bonds with warrants for KRW 20,000,000,000 and registered convertible preferred stock of 1,605,137 at a price of KRW 6,230 per share for KRW 10,000,003,510 for gross proceeds of KRW 30,000,003,510 on February 12, 2018. The bonds will mature on April 30, 2021. The bonds will bear zero interest with yield to maturity of 3%. The lump-sum amount will be payable on redemption of principal on maturity date for the bonds. The warrants will be 100% convertible into common shares at a price of KRW 7,160 per share from May 1, 2019 to April 30, 2021. The preferred stock will be convertible from May 1, 2019 to April 30, 2022. The preferred stock will have restriction period of one year. The bonds will be issued at par value and preferred stock will be issued at discount of 10%. The transaction subscription date is February 14, 2018 and payment is date is April 30, 2018. The warrants will be converted into 2,793,296 shares and convertible preferred stock will be convertible into 1,605,137 common shares. The transaction will include participation from special purpose company that will be established by the management agent under the capital market and financial investment business act. The transaction has been approved by the board of directors of the company.